Industry & Hardware
Molecular Assemblies
United States
aliveseries-b
series-b
Stage
3
Investors
About
Develops an evolved polymerase enzyme that rapidly synthesizes ultra-long DNA oligonucleotides (150+ bases) and eliminates the need for purification by excluding incomplete products during synthesis, targeting applications in gene editing and synthetic biology.
Explore Molecular Assemblies's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.